From the review of our work and that of others, we conclude that the amelioration of obesity by ELE in rodents may depend on additive or synergistic effects of combinations, such as β-agonist activation by SCFAs with ASP treatment (Figure 5) and ANP secretion with GEA treatment (Figure 6). Here, NPPA is linked to obesity due to melanocortin 4 receptor deficiency.